These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3886415)
21. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845 [TBL] [Abstract][Full Text] [Related]
22. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics. Brogard JM; Pinget M; Dorner M Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160 [TBL] [Abstract][Full Text] [Related]
23. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Giugliano D; Luyckx AS; Lefebvre PJ Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660 [TBL] [Abstract][Full Text] [Related]
24. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. Shilo S; Sotsky M; Shamoon H J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178 [TBL] [Abstract][Full Text] [Related]
25. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Paolisso G; Passariello N; Pizza G; Marrazzo G; Giunta R; Sgambato S; Varricchio M; D'Onofrio F Acta Endocrinol (Copenh); 1989 Jul; 121(1):16-20. PubMed ID: 2662695 [TBL] [Abstract][Full Text] [Related]
26. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Iwasaki Y; Kondo K; Hasegawa H; Oiso Y Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552 [TBL] [Abstract][Full Text] [Related]
28. Outcome of the glucagon test depends upon the prevailing blood glucose concentration in type I (insulin-dependent) diabetic patients. Madsbad S; Sauerbrey N; Møller-Jensen B; Krarup T; Kühl C Acta Med Scand; 1987; 222(1):71-4. PubMed ID: 3630779 [TBL] [Abstract][Full Text] [Related]
29. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes. Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440 [TBL] [Abstract][Full Text] [Related]
30. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773 [TBL] [Abstract][Full Text] [Related]
31. [Insulin resistance and insulin secretion in type II non-obese diabetics]. Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572 [TBL] [Abstract][Full Text] [Related]
32. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus. Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170 [TBL] [Abstract][Full Text] [Related]
33. Fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in non-insulin-dependent diabetics and in control subjects. Sarlund H; Laakso M; Pyörälä K; Penttilä I Acta Med Scand; 1987; 221(4):377-83. PubMed ID: 3604753 [TBL] [Abstract][Full Text] [Related]
34. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. Palmer JP; Benson JW; Walter RM; Ensinck JW J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201 [TBL] [Abstract][Full Text] [Related]
35. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity. Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266 [TBL] [Abstract][Full Text] [Related]
36. Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics. Kyllästinen M; Elfving S Gerontology; 1986; 32(6):317-26. PubMed ID: 3556328 [TBL] [Abstract][Full Text] [Related]
37. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. Larsson H; Berglund G; Ahrén B J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Hendriksen C; Faber OK; Drejer J; Binder C Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408 [TBL] [Abstract][Full Text] [Related]
39. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R Diabetes; 2007 Apr; 56(4):1113-9. PubMed ID: 17395750 [TBL] [Abstract][Full Text] [Related]
40. Comparison of glucose, glucagon and standard meal-induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus. Tai WH; Jap TS; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1988 Nov; 42(5):353-8. PubMed ID: 3076501 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]